Literature DB >> 35428867

Melanoma-associated retinopathy after starting immunotherapy for metastatic cutaneous melanoma.

Mariantonia Ferrara1, Wendy Adams1, Ajay Kotagiri2.   

Abstract

Entities:  

Year:  2022        PMID： 35428867     DOI： 10.1038/s41433-022-02057-8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Melanoma-associated retinopathy treated with ipilimumab therapy.

Authors:  A Audemard; S de Raucourt; S Miocque; F Comoz; J M Giraud; B Dreno; B Bienvenu; M-J Rogerie; A Dompmartin
Journal:  Dermatology       Date:  2013-09-14       Impact factor: 5.366

2.  Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.

Authors:  C Pföhler; A Haus; A Palmowski; S Ugurel; K W Ruprecht; C E Thirkill; W Tilgen; U Reinhold
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

3.  Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review.

Authors:  Jacob S Heng; Jenna M Kim; D Kyle Jones; Kathleen M Stoessel; Sarah A Weiss; Mario Sznol; Harriet M Kluger; Scott D Walter; Niki A Silverstein; Renelle Pointdujour-Lim
Journal:  BMJ Open Ophthalmol       Date:  2022-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.